Tag Archives: Purdue

Fears Nachawati’s Jonathan Novak Featured in AP News Story About Purdue Pharma’s Landmark Opioid Settlement

Following the announcement that OxyContin maker Purdue Pharma had reached a landmark settlement with the state of Oklahoma for damages caused by opioid addition, the Associated Press spoke with Fears Nachawati trial lawyer Jonathan Novak about the significance of the … Continue reading

Posted in Bankruptcy Law | Tagged , , , , , , , , , , , | Leave a comment

Purdue Pharma Executives Wanted to Get into Anti-Addiction Market

Lawsuit claims Purdue Pharma and the Sackler family had planned to get into the anti-addiction market. The company boosted sales of OxyContin will discussing these plans so its executives could profit on both ends. Read more detail on Recent Products … Continue reading

Posted in Products Liability | Tagged , , , , , , | Leave a comment

Purdue Pharma Marketed Oxycontin As Less Addictive, Despite Known Abuse

Purdue Pharma, maker of OxyContin and lesser known MS Contin, is facing scrutiny after several recent articles exposed information from a Justice Department investigation into the company. The investigation focused on evidence that showed Purdue’s legal council and executives were … Continue reading

Posted in Medical malpractice law | Tagged , , , , , , , , | Leave a comment

Purdue Issues New Plan Following Senator’s Report Regarding Opioid Epidemic

Purdue Issues New Plan Following Senator's Report Regarding Opioid Epidemic The post Purdue Issues New Plan Following Senator’s Report Regarding Opioid Epidemic appeared first on Legal Reader. Read more detail on Recent Products Liability posts –

Posted in Products Liability | Tagged , , , , , , , , | Leave a comment

Pharmaceutical Executives and In-House Counsel Beware: U.S. District Court Affirms Exclusion of Former Purdue Executives Under "Responsible Corporate Officer" Doctrine

On December 13, 2010, the United States District Court for the District of Columbia affirmed the decision of Kathleen Sebelius, Secretary of the Department of Health and Human Services (the "Secretary") excluding three former pharmaceutical executives for twelve years from … Continue reading

Posted in Administrative law | Tagged , , , , , , , , , , , , , , , | Leave a comment